Company intelligence / Profile preview

Gene-X BioConsulting

United Statesangelica0317.wordpress.com ↗

Ownership: Private
Development stage: Other

Overview

Gene-X BioConsulting provides preclinical strategies and solutions to early- and late-stage companies and academic investigators developing cell and gene therapies. The founder, Gary Mansfield, has extensive experience in product development, operations, translational research, due diligence efforts, team management, program oversight, and CRO/CMO activities. The company supports clients globally across the cell and gene therapy landscape but does not itself sponsor clinical programs or products.

Therapeutic areas: Rare Diseases
Modalities: Cell therapyGene therapy
Industry: Consulting

Partnerships

Gary Mansfield is also a partner at Alacrita Consulting; no other major partnerships listed.

Beyond the preview

Go deeper on Gene-X BioConsulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene-X BioConsulting.

Explore the full profile